Prognostic models predicting survival of patients with brain metastases: Integration of lactate dehydrogenase, albumin and extracranial organ involvement

Clinical Oncology

Volumn 26, Issue 8, 2014, Pages 447-452

  Nieder, C ^a,b   Marienhagen, K ^c   Dalhaug, A ^a,b   Aandahl, G ^a   Haukland, E ^a   Pawinski, A ^a  

^a NORDLAND HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Albumin; Best supportive care; Brain metastases; Lactate dehydrogenase; Prognostic factors; Radiotherapy

Indexed keywords

ALBUMIN; LACTATE DEHYDROGENASE; SERUM ALBUMIN;

ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ASSESSMENT TOOL; COLORECTAL CANCER; DIAGNOSIS SPECIFIC GRADED PROGNOSTIC ASSESSMENT; FEMALE; FOLLOW UP; HUMAN; KARNOFSKY PERFORMANCE STATUS; KIDNEY CANCER; KIDNEY CARCINOMA; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL PREDICTION; SURVIVAL RATE; ANALYSIS OF VARIANCE; BRAIN NEOPLASMS; KAPLAN MEIER METHOD; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PROGNOSIS; REGRESSION ANALYSIS; SECONDARY; STATISTICAL MODEL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM METASTASIS; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SERUM ALBUMIN; YOUNG ADULT;

EID: 84903817122     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2014.03.006     Document Type: Article

References (27)

1. Sperduto P.W., Chao S.T., Sneed P.K., et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010, 77:655-661.
2. Sperduto P.W., Kased N., Roberge D., et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. JClin Oncol 2012, 30:419-425.
3. Zindler J.D., Rodrigues G., Haasbeek C.J., et al. The clinical utility of prognostic scoring systems in patients with brain metastases treated with radiosurgery. Radiother Oncol 2013, 106:370-374.
4. Antoni D., Clavier J.B., Pop M., Schumacher C., Lefebvre F., Noël G. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors. Int J Radiat Oncol Biol Phys 2013, 86:630-637.
5. Likhacheva A., Pinnix C.C., Parikh N., et al. Validation of recursive partitioning analysis and diagnosis-specific graded prognostic assessment in patients treated initially with radiosurgery alone. JNeurosurg 2012, 117(Suppl.):38-44.
6. Nieder C., Andratschke N.H., Geinitz H., Grosu A.L. Diagnosis-specific graded prognostic assessment score is valid in patients with brain metastases treated in routine clinical practice in two European countries. Med Sci Monit 2012, 18:CR450-CR455.
7. Nieder C., Norum J., Dalhaug A., Aandahl G., Engljähringer K. Best supportive care in patients with brain metastases and adverse prognostic factors: development of improved decision aids. Support Care Cancer 2013, 21:2671-2678.
8. Feliu J., Jiménez-Gordo A.M., Madero R., et al. Development and validation of a prognostic nomogram for terminally ill cancer patients. JNatl Cancer Inst 2011, 103:1613-1620.
9. Nieder C., Marienhagen K., Dalhaug A., Norum J. Towards improved prognostic scores predicting survival in patients with brain metastases: a pilot study of serum lactate dehydrogenase levels. Scientific World J 2012, 2012:609323.
10. Nieder C., Dalhaug A. Anew prognostic score derived from phase I study participants with advanced solid tumours is also valid in patients with brain metastasis. Anticancer Res 2010, 30:977-979.
11. Nieder C., Pawinski A., Molls M. Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status?. Clin Oncol (R Coll Radiol) 2010, 22:65-69.
12. Nieder C., Andratschke N.H., Geinitz H., Grosu A.L. Use of the Graded Prognostic Assessment (GPA) score in patients with brain metastases from primary tumours not represented in the diagnosis-specific GPA studies. Strahlenther Onkol 2012, 188:692-695.
13. Gaspar L., Scott C., Rotman M., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745-751.
14. Lorenzoni J., Devriendt D., Massager N., et al. Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys 2004, 60:218-224.
15. Sperduto P.W., Berkey B., Gaspar L.E., Mehta M., Curran W. Anew prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008, 70:510-514.
16. Lagerwaard F.J., Levendag P.C., Nowak P.J., Eijkenboom W.M., Hanssens P.E., Schmitz P.I. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999, 43:795-803.
17. Weltman E., Salvajoli J.V., Brandt R.A., et al. Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys 2000, 46:1155-1161.
18. Rades D., Dunst J., Schild S.E. Anew scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol 2008, 184:251-255.
19. Rades D., Dziggel L., Haatanen T., et al. Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases. Int J Radiat Oncol Biol Phys 2011, 80:1122-1127.
20. Rades D., Dziggel L., Nagy V., et al. Anew survival score forpatients with brain metastases who received whole-brainradiotherapy (WBRT) alone. Radiother Oncol 2013, 108:123-127.
21. Nieder C., Mehta M.P. Prognostic indices for brain metastases - usefulness and challenges. Radiat Oncol 2009, 4:10.
22. Rades D., Gerdan L., Segedin B., et al. Brain metastasis: prognostic value of the number of involved extracranial organs. Strahlenther Onkol 2013, 189:996-1000.
23. Staudt M., Lasithiotakis K., Leiter U., et al. Determinants of survival in patients with brain metastases from cutaneous melanoma. Br J Cancer 2010, 102:1213-1218.
24. Chatani M., Matayoshi Y., Masaki N., Inoue T. Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase. Strahlenther Onkol 1994, 170:155-161.
25. Windsor A.A., Koh E.S., Allen S., et al. Poor outcomes after whole brain radiotherapy in patients with brain metastases: results from an international multicentre cohort study. Clin Oncol (R Coll Radiol) 2013, 25:674-680.
26. Nieder C., Norum J., Dalhaug A., Aandahl G., Pawinski A. Radiotherapy versus best supportive care in patients with brain metastases and adverse prognostic factors. Clin Exp Metastasis 2013, 30:723-729.
27. Langley R.E., Stephens R.J., Nankivell M., et al. Interim data from the Medical Research Council QUARTZ trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer?. Clin Oncol (R Coll Radiol) 2013, 25:e23-e30.